156 related articles for article (PubMed ID: 8527541)
1. Meropenem versus tobramycin plus clindamycin for treatment of intraabdominal infections: results of a prospective, randomized, double-blind clinical trial.
Condon RE; Walker AP; Sirinek KR; White PW; Fabian TC; Nichols RL; Wilson SE
Clin Infect Dis; 1995 Sep; 21(3):544-50. PubMed ID: 8527541
[TBL] [Abstract][Full Text] [Related]
2. Results of a randomized, multicenter trial of meropenem versus clindamycin/tobramycin for the treatment of intra-abdominal infections.
Wilson SE
Clin Infect Dis; 1997 Feb; 24 Suppl 2():S197-206. PubMed ID: 9126694
[TBL] [Abstract][Full Text] [Related]
3. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group.
Sieger B; Berman SJ; Geckler RW; Farkas SA
Crit Care Med; 1997 Oct; 25(10):1663-70. PubMed ID: 9377880
[TBL] [Abstract][Full Text] [Related]
4. A multicenter study comparing intravenous meropenem with clindamycin plus gentamicin for the treatment of acute gynecologic and obstetric pelvic infections in hospitalized women.
Hemsell DL; Martens MG; Faro S; Gall S; McGregor JA
Clin Infect Dis; 1997 Feb; 24 Suppl 2():S222-30. PubMed ID: 9126697
[TBL] [Abstract][Full Text] [Related]
5. Meropenem versus tobramycin with clindamycin in the antibiotic management of patients with advanced appendicitis.
Berne TV; Yellin AE; Appleman MD; Heseltine PN; Gill MA
J Am Coll Surg; 1996 May; 182(5):403-7. PubMed ID: 8620275
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
7. Aztreonam plus clindamycin versus tobramycin plus clindamycin in the treatment of intraabdominal infections.
Williams RR; Hotchkin D
Rev Infect Dis; 1991; 13 Suppl 7():S629-33. PubMed ID: 2068472
[TBL] [Abstract][Full Text] [Related]
8. Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis.
Smith JA; Skidmore AG; Forward AD; Clarke AM; Sutherland E
Ann Surg; 1980 Aug; 192(2):213-20. PubMed ID: 6996625
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the activity of meropenem with that of other agents in the treatment of intraabdominal, obstetric/gynecologic, and skin and soft tissue.
Pitkin D; Sheikh W; Wilson S; Hemsell D; Nichols R; Nadler H; Dowzicky M
Clin Infect Dis; 1995 Jun; 20 Suppl 2():S372-5. PubMed ID: 7548602
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program.
Mazuski JE; Gasink LB; Armstrong J; Broadhurst H; Stone GG; Rank D; Llorens L; Newell P; Pachl J
Clin Infect Dis; 2016 Jun; 62(11):1380-1389. PubMed ID: 26962078
[TBL] [Abstract][Full Text] [Related]
11. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S
Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
[TBL] [Abstract][Full Text] [Related]
12. Cefoxitin plus tobramycin and clindamycin plus tobramycin. A prospective randomized comparison in the therapy of mixed aerobic/anaerobic infections.
Nicolle LE; Harding GK; Louie TJ; Thomson MJ; Blanchard RJ
Arch Surg; 1986 Aug; 121(8):891-6. PubMed ID: 3524511
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial.
Lucasti C; Popescu I; Ramesh MK; Lipka J; Sable C
J Antimicrob Chemother; 2013 May; 68(5):1183-92. PubMed ID: 23391714
[TBL] [Abstract][Full Text] [Related]
14. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
Birolini D; Moraes MF; de Souza OS
Chemotherapy; 1989; 35 Suppl 1():49-57. PubMed ID: 2659290
[TBL] [Abstract][Full Text] [Related]
15. Aztreonam plus clindamycin vs. tobramycin plus clindamycin for the treatment of intraabdominal infections.
Birolini D; Moraes MF; de Souza OS
Rev Infect Dis; 1985; 7 Suppl 4():S724-8. PubMed ID: 3909330
[TBL] [Abstract][Full Text] [Related]
16. A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis.
Schentag JJ; Wels PB; Reitberg DP; Walczak P; Van Tyle JH; Lascola RJ
Ann Surg; 1983 Jul; 198(1):35-41. PubMed ID: 6222710
[TBL] [Abstract][Full Text] [Related]
17. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
Colardyn F; Faulkner KL
J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
[TBL] [Abstract][Full Text] [Related]
18. A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.
Qin X; Tran BG; Kim MJ; Wang L; Nguyen DA; Chen Q; Song J; Laud PJ; Stone GG; Chow JW
Int J Antimicrob Agents; 2017 May; 49(5):579-588. PubMed ID: 28363526
[TBL] [Abstract][Full Text] [Related]
19. High-dose tobramycin combined with clindamycin or lincomycin in the treatment of septic peritonitis and intraabdominal sepsis.
Muth L; Edén T
Acta Chir Scand; 1981; 147(5):339-46. PubMed ID: 7324760
[TBL] [Abstract][Full Text] [Related]
20. Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Stellato TA; Danziger LH; Hau T; Gauderer MW; Ferron JL; Gordon N
Arch Surg; 1988 Jun; 123(6):714-7. PubMed ID: 3285809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
